Similasan Reisekrankheit, Globuli - 15 g Swissmedic Key 67812001 Registration Holder Similasan AG Name Similasan Reisekrankheit, Globuli Date of registration 16.12.2021 Introduction of Sequence 16.12.2021 ATC-Classification Antiemetika, Homöopathika (A04AZ) Revision date WHO WHO-DDD Valid until 15.12.2026 Index Therapeuticus (BSV) Show package size 15 g Index Therapeuticus (Swissmedic) 20.01.10. Description Swissmedic categorie. D SL Eintrag No Indication Information for professionals Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680678120014 Medication Code Homöopathische Arzneimittel Pharmacode Disponibility
Composition nux-vomica (Ph.Eur.Hom.) D15 (Ph.Eur.Hom. 1.1.8) 2.500 mg, hyoscyamus niger (HAB) D15 2.500 mg, petroleum rectificatum (HAB) D15 2.500 mg, anamirta cocculus (HAB) D15 (Ph.Eur.Hom. 1.1.8) 2.500 mg, calcii carbonas, xylitolum 600.00 mg, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta. Packungsbestandteile Galenic Form Globules Excipiens Active Agent Dose Anamirta Cocculus (Hab) D15 (Ph.Eur.Hom. 1.1.8) 2.5 mg Hyoscyamus Niger (Hab) D15 2.5 mg Nux-Vomica (Ph.Eur.Hom.) D15 (Ph.Eur.Hom. 1.1.8) 2.5 mg Petroleum Rectificatum (Hab) D15 2.5 mg
Inactive agents Dose Calcium Carbonate Xylitol 600 mg
Source Data was imported : 06.01.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
